Serotonergic agents and alcoholism treatment: a simulation.
... to ondansetron (a 5-HT3 receptor antagonist) than to selective serotonin reuptake inhibitor (SSRI) treatment, whereas those with late-onset alcoholism may ...
Rehabilitation Center Sources Available by Passagesmalibu.com
rehabilitation center - click here to enter, spokane drug rehabilitation, alcoholism treatment and ondansetron, substance abuse and dyslexia, new york ...
Clinical Trial: Drug Treatment for Alcoholism (ondansetron)
Drug Treatment for Alcoholism (ondansetron). This study is currently recruiting patients. Sponsored by. National Institute on Alcohol ...
Designing research protocols for pharmacotherapy trials for ...
... Determining the efficacy of combining ondansetron and naltrexone in treating other ... s effects will synergize with that of SSRIs for alcoholism treatment. ...
Treatment Of Alcoholism
... free! Clinical Trial: Drug Treatment for Alcoholism (ondansetron) ... About. Drug Treatment for Alcoholism (ondansetron) ... single ...
Ondansetron Can Prevent Alcohol Craving
... Ondansetron, manufactured by Glaxo Wellcome Inc., is FDA-approved for the treatment of chemotherapy ... doses much larger than those used in the alcoholism study ...
Nausea drug may aid alcoholism treatment: Science News Online, Aug ...
... The researchers recruited volunteers seeking alcoholism treatment at either of two substance-abuse ... to receive one of three daily dosages of ondansetron or a ...
ASREC Early Onset EtOH
... for the use in alcoholism treatment. (The aversive medication disulfiram [AntabuseTM], approved in 1948, is still in use.) Today's report on ondansetron is the ...
Clinical Trial: Ondansetron Treatment for Alcoholism
Ondansetron Treatment for Alcoholism. This study has been completed. ... Condition, Treatment or Intervention, Phase. Alcoholism, Drug: ondansetron (Zofran), Phase II ...
The Scientist :: Alcoholism treatment
... Ondansetron may be an effective treatment for patients with early-onset alcoholism, presumably ameliorating an underlying serotonergic abnormality. ...
|
|
